⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245034 | 0.91 | — | — | |
| SCHEMBL27245029 | 0.91 | — | — | |
| SCHEMBL27245132 | 0.89 | — | — | |
| SCHEMBL27245128 | 0.89 | — | — | |
| SCHEMBL27245080 | 0.84 | — | — | |
| SCHEMBL27245074 | 0.84 | — | — | |
| SCHEMBL30890580 | 0.82 | — | — | |
| SCHEMBL30890648 | 0.82 | — | — | |
| SCHEMBL30890479 | 0.82 | — | — | |
| SCHEMBL30890592 | 0.82 | ITGB3 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |